The North America Human Milk Oligosaccharides Market would witness market growth of 23.0% CAGR during the forecast period (2023-2030).
Human milk oligosaccharide (HMO) is a highly concentrated unconjugated glycan with a complex structure present in human milk. With negligible digestion in the gastrointestinal tract, HMOs reach the colon unaltered, where they exert their influence on the microbiota. As HMOs are beneficial for immunity, several new techniques are being developed by key players in the market, such as isolating HMO from cow milk, employing costly techniques, or utilizing microbes to produce them. market products are expensive, as a large amount of human milk is synthesized to make a small amount of HMO. As a result, techniques for synthesis and extraction are improving with continuous research and development activities.
The functional benefits of these products have created a massive demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. One of the significant factors and market trends that boosts the its growth is the availability of new technologies like enzymatic trans-glycosylation, which is used for artificially synthesizing the HMOs.
According to Statistics Canada, in 2020, fortified/functional (FF) foods and beverages represented the highest sales value in the US within the health and wellness (H&W) foods and beverage sector at US$67.9 billion. The increasing emphasis on wellness and health has led consumers in the US to seek functional foods and beverages that go beyond essential nutrition. HMOs, known for their potential prebiotic and immune-modulating properties, align with these health-focused preferences. The food and beverage industry in the US is known for its innovation in product formulations. The above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $151,168.8 Thousand by 2030. The Canada market is experiencing a CAGR of 25.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 24.7% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A).
Human milk oligosaccharide (HMO) is a highly concentrated unconjugated glycan with a complex structure present in human milk. With negligible digestion in the gastrointestinal tract, HMOs reach the colon unaltered, where they exert their influence on the microbiota. As HMOs are beneficial for immunity, several new techniques are being developed by key players in the market, such as isolating HMO from cow milk, employing costly techniques, or utilizing microbes to produce them. market products are expensive, as a large amount of human milk is synthesized to make a small amount of HMO. As a result, techniques for synthesis and extraction are improving with continuous research and development activities.
The functional benefits of these products have created a massive demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. One of the significant factors and market trends that boosts the its growth is the availability of new technologies like enzymatic trans-glycosylation, which is used for artificially synthesizing the HMOs.
According to Statistics Canada, in 2020, fortified/functional (FF) foods and beverages represented the highest sales value in the US within the health and wellness (H&W) foods and beverage sector at US$67.9 billion. The increasing emphasis on wellness and health has led consumers in the US to seek functional foods and beverages that go beyond essential nutrition. HMOs, known for their potential prebiotic and immune-modulating properties, align with these health-focused preferences. The food and beverage industry in the US is known for its innovation in product formulations. The above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $151,168.8 Thousand by 2030. The Canada market is experiencing a CAGR of 25.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 24.7% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A).
Scope of the Study
Market Segments Covered in the Report:
By Application- Infant Formula
- Functional Food & Beverages
- Food Supplements
- Others (Clinical Nutrition & Pharmaceuticals)
- 2'FL
- 3'FL
- 3'SL
- 6'SL
- Neutral
- Acidic
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- BASF SE
- Chr.Hansen Holding A/S
- DuPont de Nemours, Inc.
- Nestle S.A
- Inbiose NV
- Biosynth AG
- Abbott Laboratories
- Royal FrieslandCampina N.V.
- Dextra Laboratories Ltd (ICE S.p.A)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Human Milk Oligosaccharides Market, by Application
Chapter 6. North America Human Milk Oligosaccharides Market, by Type
Chapter 7. North America Human Milk Oligosaccharides Market, by Concentration
Chapter 8. North America Human Milk Oligosaccharides Market, by Country
Chapter 9. Company Profiles
Companies Mentioned
- Koninklijke DSM N.V.
- BASF SE
- Chr. Hansen Holding A/S
- DuPont de Nemours, Inc.
- Nestle S.A
- Inbiose NV
- Biosynth AG
- Abbott Laboratories
- Royal FrieslandCampina N.V.
- Dextra Laboratories Ltd (ICE S.p.A)
Methodology
LOADING...
